COVID-19 Saliva Sampling Test Potential Market Snapshot (2022-2032)
[250 Pages Report] Newly released COVID-19 Saliva Sampling Test Potential Market analysis report by Future Market Insights shows that global sales of COVID-19 Saliva Sampling Test Potential Market in 2021 were held at US$ 3.1 Bn. With 5.1%, theprojectedmarketgrowthduring2022 - 2032 is expected to be significantly higher than the historical growth. Fluorescence-labeled antigen/antibodies testing is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 5.1% during 2022 – 2032.
Attributes
Details
Covid-19 Saliva Sampling Test Potential Market CAGR (2022 – 2032)
5.1%
Covid-19 Saliva Sampling Test Potential Market Size (2022)
US$ 3.3 Billion
Covid-19 Saliva Sampling Test Potential Market Size (2032)
US$ 5.4 Billion
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Revenue of COVID-19 Saliva Sampling Test Potential Market from 2019 to 2021 Compared to Demand Outlook for 2022 to 2032
As per the COVID-19 Saliva Sampling Test Potential Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2019 to 2021, market value of the COVID-19 Saliva Sampling Test Potential Market increased at around 4.3% CAGR.
In the next few years, concerns about the spread of a SARS-CoV-2 variant are expected to raise the necessity for comprehensive Sampling and surveillance techniques that will be followed by an increase in demand for COVID-19 saliva Sampling tests. This is likely to lead to an increase in demand for COVID-19 saliva Sampling test potential between the years 2022 and 2032.
As the cases of people visiting public places grow, visitors have begun to predominate in some locations worldwide, leading to an increase in demand for testing at point-of-care to determine whether a person is contagious with the coronavirus disease (COVID-19). This has fuelled technological innovation, which is spurring improvements in the sequencing of saliva-based diagnostic tests to prevent viral transmission from asymptomatic individuals.
Fluorescence-labelled antigen/antibody testing allows for the rapid identification of contagious individuals and is an effective Sampling modality for cruise ships, aeroplanes, sports stadiums, and schools. The combination of vaccination and rapid and frequent testing with fluorescence-labelled antigen/antibodies tests has the potential to end the pandemic. The system for fluorescence-labelled antigen/antibody testing is intended to accelerate rapid point-of-access testing of individuals by utilizing the principles of fluorescence detection, biochemistry, robotics automation, and cloud computing.
Owing to the physiological changes associated with ageing and potential underlying health conditions, the ageing population is at a high risk of developing severe illness. Poor health status, decreased organ function, weakened immune function, an increased likelihood of multiple underlying diseases, and a lack of attention to personal health can all increase susceptibility to various diseases in the elderly. As a result, the growing population of people over the age of 65 indicates that a greater proportion of people in this age group are at risk of contracting the disease. As a result, the ageing population is more vulnerable to viral infections, which will increase demand for COVID-19 saliva-based Sampling.
According to a study conducted in 2020, 23,487 fatality cases were reported in a population of 25 million men over the age of 65, while 2,765 fatality cases were reported in a population of 31 million women over the age of 65 in the United States. The new COVID-19 saliva test is thought to make testing easier for people of all ages because the saliva-based method allows for simpler and faster sample collection.
COVID-19 Saliva Sampling Test Potential Market was valued at US$ 3.1 Bn in 2021. According to Future Market Insights, COVID-19 Saliva Sampling Test Potential Market revenue would increase 1.6X between 2022 and 2032, reaching roughly US$ 5.4 Bn in 2032.
In terms of Technology, the Fluorescence-labelled antigen/antibodies Testingaccounts for the highest projected CAGR of over 5.1%.
In terms of Modes of COVID-19 Saliva Sampling Test Potential, Centralized Testing accounts for the highest CAGR of 5.1% during the historic period (2019-21).
US is the dominant region in COVID-19 Saliva Sampling Test Potential Market with an absolute dollar growth opportunity of over US$ 1.7 Bn.
Which Factors are Propelling COVID-19 Saliva Sampling Test Potential Demand?
The timeline and cost constraints on molecular swab-based SARS-CoV-2 Sampling are prompting customers to shift to saliva-based testing to screen for the virus, which is driving market growth. The emergence of SARS-CoV-2 variants in South Africa, the United Kingdom, and Brazil, which stemmed from radical Islam, drives people toward greater testing to quickly detect emerging strains. Concerns about the widespread nature of these variants are expected to fuel demand for surveillance and testing among the general public.
In these programmes, the Fluorescence-labelled antigen/antibody testing Pandemic Défense Platform was found to be effective. Vaccine administration alone is unlikely to be sufficient; mass Sampling will be required for businesses to reopen.
Shorter testing times, user-friendliness, and a patient-friendly nature are just a few of the factors driving this test's growing popularity. These factors are apt to help contribute to the growth in the COVID-19 saliva Sampling test potential market in the coming years. Despite high market penetration and continued scientific development, the challenges associated with the methodology of swab-based testing are likely to hold market growth back.
Find your sweet spots for generating winning opportunities in this market.
What are the most promising opportunities for COVID-19 Saliva-based Sampling Product Manufacturers?
Owing to the virus's outbreak and rapid spread, countries have imposed mandatory guidelines for COVID-19 diagnostics and other activities such as travel. Many countries have made it mandatory to have a negative COVID-19 test in order to travel internationally or domestically.
Furthermore, in order to break the chain, government guidelines have included testing of people who may have come into contact with infected people. The increase in the number of tests as a result of government standards and guidelines represents significant growth opportunities for COVID-19 saliva-based Sampling.
Region-wise Analysis
Which Region is projected to Offer the Largest Opportunity for COVID-19 Saliva Sampling Test Potential Market?
In 2021, North America accounted for the largest proportion of revenue in the worldwide COVID-19 Saliva Sampling Test Potential market. It is expected to continue maintaining a significant portion over the forecast period. New products introduced by emerging start-ups have led to the emergence of home grown businesses developing and manufacturing processes for a variety of diagnostic tests and Sampling tools. The growth of this vital industry is contributing to the area's economic dominance.
The ICAO Air Transport Bureau expects that there will be an overall decrease in airline passengers of up to 60% in 2020. Revenue from airline in North America was reduced by US$ 88 Bn. This indicates that the North American region has a high potential for economic growth by using saliva-based COVID-19 Sampling tests.
Which Region is estimated to be the Fastest-growing COVID-19 Saliva Sampling Test Potential Market during the Forecast Period?
Considerations for using saliva as a diagnostic tool to detect COVID-19 were identified in May 2021 by the European Centre for Disease Prevention and Control. According to this report, commercial tests based on saliva specimens are legal in the European Union and are marked CE.
The European Medicines Agency (EMA) has granted various companies authorizations for their marketing of their products in Europe, thereby increasing the market potential for saliva-based Sampling tools in this region. Also, increasing awareness about the use of saliva-based Sampling tests in order to circumvent the spread of COVID-19 and changing lifestyles will lead to an increase in market growth in Europe.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Country-wise Analysis
Which Country Lies at the CenterStage for COVID-19 Saliva Sampling Test Potential Market Revenue?
The United States is expected to have the highest market share of US$ 4.4 Bn by the end of 2032. The FDA is critical in safeguarding the country’s population from newer infectious disease threats such as the COVID-19 outbreak. The FDA is committed to provide appropriate guidance to support response efforts to the COVID-19 pandemic, which is expected to benefit market growth in the United States.
Category-wise Insights
Why Fluorescence-labelled antigen/antibodies Testing is projected to WiBness Fastest Growth among COVID-19 Saliva Sampling Test Potential Technology?
Fluorescence-labelled antigen/antibodies Testing segment is forecasted to grow at the highest CAGR of over 5.1% during 2022-2032. Fluorescence-labelled antigen/antibody testing is well-suited for a high-traffic, high-risk pandemic ecosystem, which includes manufacturing facilities, hospitals and large healthcare facilities, corporate campuses, athletic stadiums, transportation and distribution hubs, schools and colleges, shopping centres, performance venues, airline and cruise ship terminals, and other large business and retail settings. As a result, the saliva-based COVID-19 Sampling market has a lot of room to grow in the near future.
Which Mode of COVID-19 Saliva Sampling Test Potential is expected to Score Highest Growth in the Coming Years?
Centralized Testing commanded the highest price as well as CAGR of 5.1% from the period 2012 to 2023, whereas centralised testing held in the medical sector was the fastest growing segment of the market. As diagnostic tests are often carried out in a centralised method, legislation that would mandate its execution could be hugely profitable.
The main principle of saliva-based COVID-19 diagnosis by centralised settings is the ease of sample collection. The minimized need for specimen collection reduces the volume of collection supplies that have been required for diagnostic saliva testing. Fewer tests are required in the testing protocol. Furthermore, laboratories have access to diagnostic testing machines.
Competitive Analysis
Players in the market are constantly developing innovative solutions as well as extending their product offerings. To help healthcare organisations implement data analysis solutions, combat the Covid-19 pandemic, and preserve competitive advantage in the market, the companies are focused on their alliances, technology collaborations, and product launch strategies.
Some of the recent developments of key COVID-19 Saliva Sampling Test Potential providers are as follows:
In April 2021, Chembio Diagnostics, Inc. developed a rapid POCT licensed for use in both decentralized and traditional diagnostic laboratories in response to orders for COVID-19 tests. This product's stock was immediately available for the construction of customers throughout the U.S.
In April 2021, Vatic Health received the CE mark for its on-the-spot SARS-CoV-2 virus saliva antigen test. The test has also been registered with the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom.
In March 2020, ID NOW, a molecular POCT for detecting novel coronavirus (COVID-19), was launched by Abbott after receiving an Emergency Use Authorization from the U.S. Food and Drug Administration (EUA). It is small, lightweight (6.6 pounds), and portable (the size of a small toaster), and it employs molecular technology to produce positive results in as little as five minutes and negative results in as little as 13 minutes.
Similarly, recent developments related to companies COVID-19 Saliva Sampling Test Potential services have been tracked by the team at Future Market Insights, which are available in the full report.
COVID-19 Saliva Sampling Test Potential Market Report Scope
Attribute
Details
Forecast Period
2022 to 2032
Historical Data Available for
2019 to 2021
Market Analysis
US$ Billion for Value
Key Regions Covered
North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Key Countries Covered
United States, Canada, Brazil, Mexico, Germany, U.K., France, Spain, Italy, Russia, China, Japan, South Korea, India, Australia, South Africa, Saudi Arabia, UAE and Israel.
Market Segments Covered in COVID-19 Saliva Sampling Test Potential Market Analysis
By Location:
Travel Stations
Sports Arenas
Entertainment Venues
Corporate Campus Environments
Universities & Colleges
Factories
By Technology:
Fluorescence-labeled antigen/antibodies testing
RT-PCR
CRISPR-Cas9
By Mode:
Centralized Testing
Decentralized Testing
By Region:
North America
Latin America
Europe
APAC
MEA
Frequently Asked Questions
How much is the current worth of the COVID-19 Saliva Sampling Test Potential Market?
The global COVID-19 Saliva Sampling Test Potential Market is worth more than US$ 3.3 Bn at present.
What is the sales forecast for COVID-19 Saliva Sampling Test Potential Market?
Value of COVID-19 Saliva Sampling Test Potential Market are projected to increase at a CAGR of around 5.1% during 2022 – 2032.
What was the last 5 year’s market CAGR?
Value of COVID-19 Saliva Sampling Test Potential Market increased at a CAGR of around 4.3% during 2019 – 2021.
What is a key trend shaping the growth of the market for COVID-19 Saliva Sampling Test Potential Market?
Several major players are concentrating on advancements in in-vitro diagnostic procedures with rapid testing, as well as expanding their product portfolios.
At what percentage is sales of COVID-19 Saliva Sampling Test Potential Market going to register growth in China?
The market for COVID-19 Saliva Sampling Test Potential Market in China is projected to expand at a CAGR of around 5.2% during 2022 – 2032.
What do statistics for South Korea and Japan reveal?
While the market in South Korea is expected to grow at nearly 4.3%, the market in Japan is projected to register a CAGR of nearly 4.2% during 2022 - 2032.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
4. Global COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Location
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Location, 2019-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Location, 2022-2032
5.3.1. Travel Stations
5.3.2. Sports Arenas
5.3.3. Entertainment Venues
5.3.4. Corporate Campus Environment
5.3.5. Universities & Colleges
5.3.6. Factories
5.4. Y-o-Y Growth Trend Analysis By Location, 2019-2021
5.5. Absolute $ Opportunity Analysis By Location, 2022-2032
6. Global COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Technology
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2019-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032
6.3.1. Fluorescent-labeled antigen/ antibodies Testing
6.3.2. RT-PCR
6.3.3. CRISPR-Cas9
6.4. Y-o-Y Growth Trend Analysis By Technology, 2019-2021
6.5. Absolute $ Opportunity Analysis By Technology, 2022-2032
7. Global COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Mode
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Mode, 2019-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Mode, 2022-2032
7.3.1. Centralized Testing
7.3.2. Decentralized Testing
7.4. Y-o-Y Growth Trend Analysis By Mode, 2019-2021
7.5. Absolute $ Opportunity Analysis By Mode, 2022-2032
8. Global COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Location
9.2.3. By Technology
9.2.4. By Mode
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Location
9.3.3. By Technology
9.3.4. By Mode
9.4. Key Takeaways
10. Latin America COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Location
10.2.3. By Technology
10.2.4. By Mode
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Location
10.3.3. By Technology
10.3.4. By Mode
10.4. Key Takeaways
11. Europe COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. BENELUX
11.2.1.8. Rest of Europe
11.2.2. By Location
11.2.3. By Technology
11.2.4. By Mode
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Location
11.3.3. By Technology
11.3.4. By Mode
11.4. Key Takeaways
12. Asia Pacific COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. India
12.2.1.5. Rest of Asia Pacific
12.2.2. By Location
12.2.3. By Technology
12.2.4. By Mode
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Location
12.3.3. By Technology
12.3.4. By Mode
12.4. Key Takeaways
13. MEA COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC
13.2.1.2. Rest of MEA
13.2.2. By Location
13.2.3. By Technology
13.2.4. By Mode
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Location
13.3.3. By Technology
13.3.4. By Mode
13.4. Key Takeaways
14. Key Countries COVID-19 Saliva Sampling Test Potential Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Location
14.1.2.2. By Technology
14.1.2.3. By Mode
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Location
14.2.2.2. By Technology
14.2.2.3. By Mode
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Location
14.3.2.2. By Technology
14.3.2.3. By Mode
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Location
14.4.2.2. By Technology
14.4.2.3. By Mode
14.5. Argentina
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Location
14.5.2.2. By Technology
14.5.2.3. By Mode
14.6. Germany
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Location
14.6.2.2. By Technology
14.6.2.3. By Mode
14.7. Italy
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Location
14.7.2.2. By Technology
14.7.2.3. By Mode
14.8. France
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Location
14.8.2.2. By Technology
14.8.2.3. By Mode
14.9. U.K.
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Location
14.9.2.2. By Technology
14.9.2.3. By Mode
14.10. Spain
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Location
14.10.2.2. By Technology
14.10.2.3. By Mode
14.11. Russia
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Location
14.11.2.2. By Technology
14.11.2.3. By Mode
14.12. BENELUX
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Location
14.12.2.2. By Technology
14.12.2.3. By Mode
14.13. China
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Location
14.13.2.2. By Technology
14.13.2.3. By Mode
14.14. Japan
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Location
14.14.2.2. By Technology
14.14.2.3. By Mode
14.15. South Korea
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Location
14.15.2.2. By Technology
14.15.2.3. By Mode
14.16. India
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Location
14.16.2.2. By Technology
14.16.2.3. By Mode
14.17. GCC Countries
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Location
14.17.2.2. By Technology
14.17.2.3. By Mode
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Location
15.3.3. By Technology
15.3.4. By Mode
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. ARUP Laboratories
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segment
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Vatic Health
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segment
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Mogene
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segment
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Psomagen Inc.
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segment
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. DxTerity Diagnostics Inc.
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segment
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Chemibo Diagnostics
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segment
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Abbott
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segment
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
17. Assumptions & Acronyms Used18. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Region, 2019-2032
Table 2: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Location, 2019-2032
Table 3: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Technology, 2019-2032
Table 4: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Mode, 2019-2032
Table 5: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Country, 2019-2032
Table 6: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Location, 2019-2032
Table 7: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Technology, 2019-2032
Table 8: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Mode, 2019-2032
Table 9: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Country, 2019-2032
Table 10: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Location, 2019-2032
Table 11: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Technology, 2019-2032
Table 12: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Mode, 2019-2032
Table 13: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Country, 2019-2032
Table 14: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Location, 2019-2032
Table 15: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Technology, 2019-2032
Table 16: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Mode, 2019-2032
Table 17: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Country, 2019-2032
Table 18: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Location, 2019-2032
Table 19: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Technology, 2019-2032
Table 20: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Mode, 2019-2032
Table 21: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Country, 2019-2032
Table 22: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Location, 2019-2032
Table 23: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Technology, 2019-2032
Table 24: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Mode, 2019-2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Location, 2022-2032
Figure 2: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Technology, 2022-2032
Figure 3: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Mode, 2022-2032
Figure 4: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Region, 2022-2032
Figure 5: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Region, 2019-2032
Figure 6: Global COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 7: Global COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 8: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Location, 2019-2032
Figure 9: Global COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Location, 2022-2032
Figure 10: Global COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Location, 2022-2032
Figure 11: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Technology, 2019-2032
Figure 12: Global COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 13: Global COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 14: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Mode, 2019-2032
Figure 15: Global COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Mode, 2022-2032
Figure 16: Global COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Mode, 2022-2032
Figure 17: Global COVID-19 Saliva Sampling Test Potential Market Attractiveness by Location, 2022-2032
Figure 18: Global COVID-19 Saliva Sampling Test Potential Market Attractiveness by Technology, 2022-2032
Figure 19: Global COVID-19 Saliva Sampling Test Potential Market Attractiveness by Mode, 2022-2032
Figure 20: Global COVID-19 Saliva Sampling Test Potential Market Attractiveness by Region, 2022-2032
Figure 21: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Location, 2022-2032
Figure 22: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Technology, 2022-2032
Figure 23: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Mode, 2022-2032
Figure 24: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Country, 2022-2032
Figure 25: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Country, 2019-2032
Figure 26: North America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 27: North America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 28: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Location, 2019-2032
Figure 29: North America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Location, 2022-2032
Figure 30: North America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Location, 2022-2032
Figure 31: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Technology, 2019-2032
Figure 32: North America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 33: North America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 34: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Mode, 2019-2032
Figure 35: North America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Mode, 2022-2032
Figure 36: North America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Mode, 2022-2032
Figure 37: North America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Location, 2022-2032
Figure 38: North America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Technology, 2022-2032
Figure 39: North America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Mode, 2022-2032
Figure 40: North America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Country, 2022-2032
Figure 41: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Location, 2022-2032
Figure 42: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Technology, 2022-2032
Figure 43: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Mode, 2022-2032
Figure 44: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Country, 2022-2032
Figure 45: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Country, 2019-2032
Figure 46: Latin America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 47: Latin America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 48: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Location, 2019-2032
Figure 49: Latin America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Location, 2022-2032
Figure 50: Latin America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Location, 2022-2032
Figure 51: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Technology, 2019-2032
Figure 52: Latin America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 53: Latin America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 54: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Mode, 2019-2032
Figure 55: Latin America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Mode, 2022-2032
Figure 56: Latin America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Mode, 2022-2032
Figure 57: Latin America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Location, 2022-2032
Figure 58: Latin America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Technology, 2022-2032
Figure 59: Latin America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Mode, 2022-2032
Figure 60: Latin America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Country, 2022-2032
Figure 61: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Location, 2022-2032
Figure 62: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Technology, 2022-2032
Figure 63: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Mode, 2022-2032
Figure 64: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Country, 2022-2032
Figure 65: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Country, 2019-2032
Figure 66: Europe COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 67: Europe COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 68: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Location, 2019-2032
Figure 69: Europe COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Location, 2022-2032
Figure 70: Europe COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Location, 2022-2032
Figure 71: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Technology, 2019-2032
Figure 72: Europe COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 73: Europe COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 74: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Mode, 2019-2032
Figure 75: Europe COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Mode, 2022-2032
Figure 76: Europe COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Mode, 2022-2032
Figure 77: Europe COVID-19 Saliva Sampling Test Potential Market Attractiveness by Location, 2022-2032
Figure 78: Europe COVID-19 Saliva Sampling Test Potential Market Attractiveness by Technology, 2022-2032
Figure 79: Europe COVID-19 Saliva Sampling Test Potential Market Attractiveness by Mode, 2022-2032
Figure 80: Europe COVID-19 Saliva Sampling Test Potential Market Attractiveness by Country, 2022-2032
Figure 81: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Location, 2022-2032
Figure 82: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Technology, 2022-2032
Figure 83: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Mode, 2022-2032
Figure 84: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Country, 2022-2032
Figure 85: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Country, 2019-2032
Figure 86: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 87: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 88: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Location, 2019-2032
Figure 89: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Location, 2022-2032
Figure 90: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Location, 2022-2032
Figure 91: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Technology, 2019-2032
Figure 92: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 93: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 94: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Mode, 2019-2032
Figure 95: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Mode, 2022-2032
Figure 96: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Mode, 2022-2032
Figure 97: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Attractiveness by Location, 2022-2032
Figure 98: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Attractiveness by Technology, 2022-2032
Figure 99: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Attractiveness by Mode, 2022-2032
Figure 100: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Attractiveness by Country, 2022-2032
Figure 101: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Location, 2022-2032
Figure 102: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Technology, 2022-2032
Figure 103: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Mode, 2022-2032
Figure 104: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Country, 2022-2032
Figure 105: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Country, 2019-2032
Figure 106: MEA COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 107: MEA COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 108: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Location, 2019-2032
Figure 109: MEA COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Location, 2022-2032
Figure 110: MEA COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Location, 2022-2032
Figure 111: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Technology, 2019-2032
Figure 112: MEA COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 113: MEA COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 114: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Mode, 2019-2032
Figure 115: MEA COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Mode, 2022-2032
Figure 116: MEA COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Mode, 2022-2032
Figure 117: MEA COVID-19 Saliva Sampling Test Potential Market Attractiveness by Location, 2022-2032
Figure 118: MEA COVID-19 Saliva Sampling Test Potential Market Attractiveness by Technology, 2022-2032
Figure 119: MEA COVID-19 Saliva Sampling Test Potential Market Attractiveness by Mode, 2022-2032
Figure 120: MEA COVID-19 Saliva Sampling Test Potential Market Attractiveness by Country, 2022-2032
